All News

Fendrick considers the current state of colorectal cancer screening in the US, emphasizing limited colonoscopy capacity and patient preferences for at-home tests.

The FDA approved oveporexton for narcolepsy type 1 in adults, marking the first orexin receptor agonist targeting the underlying biological cause of narcolepsy.

Community health workers and population health screening tactics help primary care teams address SDOH and reduce hospital utilization.

The FDA has approved mFLUSIVA, Moderna's first mRNA flu vaccine, for adults 50 and older ahead of the 2026-2027 season.

Jubril Oyeyemi, MD, and Giridhar Mallya, MD, MSHP, unpack HR 1's Medicaid work requirements and what they mean for primary care practices.

FDA approved Mucinex 12HR Cold & Fever Multi-Symptom, an OTC product combining guaifenesin, dextromethorphan, and naproxen sodium.

FDA approval of centanafadine could expand ADHD treatment for patients aged 6 years or older, but labeling and pivotal data remain unavailable.

A McGill University–led team developed a prediction model integrating pregnancy-related factors to identify cardiovascular disease risk in women aged 15 to 45.

Recent FDA actions include approvals and clearances in lipid management, CRC screening, contraception, vaginitis testing, and Alzheimer psychosis.

Prebiotic sodas contain less sugar than regular soda and fruit drinks, but a new analysis finds they still lag diet soda and sparkling water on sugar content.

Shpiner explains why patients consult AI before a visit and what physicians should do when the tool gets there first.

A Harvard-led analysis of more than 200,000 US adults found healthy plant-based diets lowered cardiometabolic risk regardless of ultra-processed food content.

The FDA-licensed product is room-temperature-stable, rapidly reconstituted, and intended for adult transfusion when other plasma products are unavailable.

Viatris' new once-weekly patch delivers norelgestromin and ethinyl estradiol, with a Pearl Index of 4.14 in the Phase 3 Luminous Study.

As World Hepatitis Day highlights global testing gaps, an expert outlines how primary care can identify at-risk patients sooner.

FDA clearance adds a noninvasive AI-based test for elevated pulmonary capillary wedge pressure to the CorVista System diagnostic platform.

HTX-001, an antisense oligonucleotide targeting WISPER lncRNA, received FDA Fast Track designation as HAYA Therapeutics advances the therapy for nHCM.

This World Hepatitis Day, 3 expert hepatologists discuss bepirovirsen's functional cure data and weigh primary care against specialized centers for delivering this treatment.